Bharat Biotech’s US partner Ocugen files EUA request with FDA for paediatric use of Covaxin

Covaxin was evaluated in three age groups: 2-6 years, 6-12 years and 12-18 years. All participants received two doses of the vaccine 28 days apart, it said.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...